M61.14
Myositis ossificans progressiva, hand and finger(s)
Clinical Classification Guidelines
Medical Intelligence & Overview
Myositis ossificans progressiva (MOP), also known as progressive myositis ossificans, is a rare condition characterized by the abnormal formation of bone tissue within muscles, tendons, and other soft tissues. When affecting the hands and fingers, it can lead to stiffness, deformity, and impaired movement. MOP is distinct from the more common form of heterotopic ossification, as it tends to be an inherited disorder with progressive symptoms that worsen over time.
Causes & Symptoms
Clinical Causes: Genetic mutations: The primary cause of MOP is a genetic mutation in the ACVR1 gene, which influences bone growth and development. Family history: The condition is inherited in an autosomal dominant pattern, meaning a family history of MOP increases the likelihood of developing the disorder. Trauma or injury: Although less common, physical trauma or injury to the hands and fingers can sometimes trigger abnormal bone formation in susceptible individuals. Other factors: Rarely, other genetic or environmental factors may contribute, but the exact cause remains primarily genetic.
Key Symptoms: Progressive stiffness of the fingers and hands, leading to difficulty in movement. Development of hard, lump-like areas within the soft tissues of the hand and fingers. Deformity of the affected digits as the abnormal bone growth extends and thickens. Pain or tenderness in the early stages, though it may diminish as the ossification progresses. Reduced dexterity and strength, impacting daily activities. Possible limb deformities that worsen over time, limiting function.
Diagnostic & Treatment
Diagnosis Path: Medical history review: Including family history and any previous injuries or trauma. Physical examination: To assess joint mobility, deformities, and palpable abnormal tissue. Imaging tests: X-rays are essential for visualizing abnormal bone formation within soft tissues. MRI and CT scans may provide more detailed imaging. Biopsy: Sometimes performed to confirm the diagnosis and rule out other conditions, though this is rarely necessary. Genetic testing: To identify mutations in the ACVR1 gene, supporting the diagnosis.
Treatment Protocols: Physical therapy: Aimed at maintaining joint mobility and preventing contractures, although overstretching should be avoided to prevent triggering additional ossification. Medications: Non-steroidal anti-inflammatory drugs (NSAIDs) may help reduce inflammation and discomfort. Surgical intervention: Typically reserved for severe deformities that impair function. Surgery is carefully considered due to potential for recurrence of ossification after procedures. Monitoring: Regular assessments to track disease progression and adapt management strategies. Supportive care: Assistive devices or splints may assist with daily functioning and joint support.
Clinical Advice & FAQs
Billing Guidance
Is M61.14 a billable ICD-10 code?
Yes, M61.14 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report M61.14?
Clinical documentation must specify the nature of Myositis ossificans progressiva, hand and finger(s) and any associated comorbidities for accurate reporting.
Cite this Clinical Reference